Anemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency

References

• Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults–United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61(46):938–943.
   PubMedGoogle Scholar
• Schneckenpointner R, Jörres RA, Meidenbauer N, et al.The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure. Int J Clin Pract 2014; 68(1):130–138.
   PubMed Web of Science ®Google Scholar
• Halpern MT, Zilberberg MD, Schmier JK, et al.Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006; 4:17.
   PubMedGoogle Scholar
• Krishnan G, Grant BJ, Muti PC, et al.Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006; 6:23.
   PubMedGoogle Scholar
• Kollert F, Tippelt A, Müller C, et al.Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013; 58(7):1204–1212.
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody SH, et al.Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29(5):923–929.
   PubMed Web of Science ®Google Scholar
• Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128(3):1201–1208.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Stanopoulos I, Pitsiou GG, et al.Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011; 82(3):237–245.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Karrar S, Hopkinson NS, Polkey MI. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration 2013; 85(2):126–131.
   PubMed Web of Science ®Google Scholar
• Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, et al.Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9(3):243–250.
   PubMedGoogle Scholar
• Shorr AF, Doyle J, Stern L, et al.Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin 2008; 24(4):1123–1130.
   PubMed Web of Science ®Google Scholar
• Ozyilmaz E, Kokturk N, Teksut G, Tatlicioglu T. Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract 2013; 67(7):691–697.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care 2011; 56(5):644–652.
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Mor R, Weu MT, et al.Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 2014; 14:24.
   PubMed Web of Science ®Google Scholar
• Kollert F, Müller C, Tippelt A, et al.Anaemia in chronic respiratory failure. Int J Clin Pract 2011; 65(4):479–486.
   PubMed Web of Science ®Google Scholar
• John M, Lange A, Hoernig S, et al.Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111(3):365–70.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370(9589):797–799.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379(9823):1341–1351.
   PubMed Web of Science ®Google Scholar
• Jankowska EA, Rozentryt P, Witkowska A, et al.Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010; 31(15):1872–1880.
   PubMed Web of Science ®Google Scholar
• Jankowska EA, von Haehling S, Anker SD, et al.Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013; 34(11):816–829.
   PubMed Web of Science ®Google Scholar
• Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012; 14(4):423–429.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Rivera S, Gabayan V, et al.IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113(9):1271–1276.
   PubMed Web of Science ®Google Scholar
• John M, Hoernig S, Doehner W, et al.Anemia and inflammation in COPD. Chest 2005; 127(3):825–829.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Pitsiou GG, Stanopoulos I, et al.Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM 2012; 105(7):657–663.
   PubMed Web of Science ®Google Scholar
• Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48(7):1066–1076.
   PubMed Web of Science ®Google Scholar
• Duru S, Bilgin E, Ardiç S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012; 7(1):31–35.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med 2012; 12(1):71–74.
   PubMed Web of Science ®Google Scholar
• Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol 2011; 154(3):289–300.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014; 28(4):671–681, vi.
   PubMed Web of Science ®Google Scholar
• Gangat N, Wolanskyj AP. Anemia of chronic disease. Semin Hematol 2013; 50(3):232–238.
   PubMed Web of Science ®Google Scholar
• Poggiali E, Migone De Amicis M, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med 2014; 25(1):12–17.
   PubMed Web of Science ®Google Scholar
• Marković M, Majkić-Singh N, Ignjatović S, Singh S. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation. Int J Lab Hematol 2007; 29(5):341–346.
   Google Scholar
• Thomas DW, Hinchliffe RF, Briggs C, et al.Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161(5):639–648.
   PubMed Web of Science ®Google Scholar
• McKeever TM, Lewis SA, Smit HA, et al.A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008; 9:67.
   PubMed Web of Science ®Google Scholar
• Obase Y, Mouri K, Shimizu H, et al.Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD. Int J Chron Obstruct Pulmon Dis 2011; 6:679–683.
   PubMed Web of Science ®Google Scholar
• Hirayama F, Lee AH, Oura A, et al.Dietary intake of six minerals in relation to the risk of chronic obstructive pulmonary disease. Asia Pac J Clin Nutr 2010; 19(4):572–577.
   PubMed Web of Science ®Google Scholar
• Smith TG, Balanos GM, Croft QP, et al.The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 2008; 586(Pt 24):5999–6005.
   PubMed Web of Science ®Google Scholar
• Markoulaki D, Kostikas K, Papatheodorou G, et al.Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med 2011; 22(1):103–107.
   PubMed Web of Science ®Google Scholar
• Tassiopoulos S, Kontos A, Konstantopoulos K, et al.Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001; 95(6):471–475.
   PubMed Web of Science ®Google Scholar
• Pavlisa G, Vrbanic V, Kusec V, Jaksic B. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci (Lond) 2004; 106(1):43–51.
   PubMed Web of Science ®Google Scholar
• Sala E, Balaguer C, Villena C, et al.Low erythropoietin plasma levels during exacerbations of COPD. Respiration 2010; 80(3):190–197.
   PubMed Web of Science ®Google Scholar
• Schönhofer B, Böhrer H, Köhler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998; 53(2):181–184.
   PubMed Web of Science ®Google Scholar
• Schönhofer B, Wenzel M, Geibel M, Köhler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26(11):1824–1828.
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Wouters EF, Mostert R, et al.A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003; 124(5):1733–1742.
   PubMed Web of Science ®Google Scholar
• Vaziri ND. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. Am J Kidney Dis 2013; 61(6):992–1000.
   PubMed Web of Science ®Google Scholar
• Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009; 2:2.
   PubMed Web of Science ®Google Scholar
• Steinbicker AU, Muckenthaler MU. Out of balance–systemic iron homeostasis in iron-related disorders. Nutrients. 2013; 5(8):3034–3061.
   PubMed Web of Science ®Google Scholar
• Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med 2005; 26(4–5):299–312.
   PubMedGoogle Scholar
• Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol 2012; 44(2):499–507.
   PubMed Web of Science ®Google Scholar
• Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: A review. Arzneimittelforschung 2010; 60(6a):399–412.
   PubMed Web of Science ®Google Scholar
• Philippot Q, Deslée G, Adair-Kirk TL, et al.Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS One 2014; 9(5):e96285.
   PubMed Web of Science ®Google Scholar
• Ross EM. Evaluation and treatment of iron deficiency in adults. Nutr Clin Care 2002; 5(5):220–224.
   PubMedGoogle Scholar
• Kurtoglu E, Ugur A, Baltaci AK, Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res 2003; 96(1–3):117–123.
   PubMed Web of Science ®Google Scholar
• Isler M, Delibas N, Guclu M, et al.Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities. Croat Med J 2002; 43(1):16–19.
   PubMed Web of Science ®Google Scholar
• Kumbasar A, Gursu M, Kaya C, et al.The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. J Nephrol 2012; 25(5):825–832.
   PubMed Web of Science ®Google Scholar
• Cavdar C, Temiz A, Yeniçerioğlu Y, et al.The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand J Urol Nephrol 2003; 37(1):77–82.
   PubMed Web of Science ®Google Scholar
• Schrier SL, Auerbach M. Treatment of the adult with iron deficiency anemia. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA (accessed September 25, 2014).
   Google Scholar
• INFED (iron dextran injection USP). Morristown (NJ): Watson Pharma, Inc.; 2009 Sept. Package insert. Available from: http://pi.actavis.com/data_stream.asp?product_group=1251&p=pi&language=E. (accessed 31 January, 2015).
   Google Scholar
• Ferrlecit (sodium ferric gluconate complex in sucrose injection). Bridgewater (NJ): Sanofi-Aventis U.S. LLC; 2011 Aug. Package insert. http://www.products.sanofi-aventis.us/ferrlecit/ferrlecit.pdf (accessed 9 October, 2014).
   Google Scholar
• Feraheme (ferumoxytol) Injection. Waltham (MA): AMAG Pharmaceuticals, Inc.; 2013 Dec. Package insert. http://www.feraheme.com/pdfs/Feraheme_Prescribing_Information.pdf (accessed 9 October, 2014).
   Google Scholar
• Venofer (iron sucrose injection, USP). Shirley (NY): American Regent, Inc.; 2014 Jan. Package insert. Available from: http://www.venofer.com/PDF/Venofer-Insert-Rev-012014.pdf (accessed 9 October, 2014).
   Google Scholar
• Injectafer (ferric carboxymaltose injection). Shirley (NY): American Regent, Inc.; 2013 July. Package insert. Available from: http://www.injectafer.com/files/Prescribing_Information.pdf (accessed 9 October, 2014).
   Google Scholar